DEV Community: Onyedikachi Onwurah

Designing Accountability Into Agentic AI for Healthcare

Onyedikachi Onwurah — Fri, 16 Oct 2026 12:01:27 +0000

Healthcare AI governance must address more than model accuracy. It must establish how system outputs become actions and who is responsible at each stage.

A practical architecture should distinguish between generating a recommendation, presenting it for review, receiving authorization, and executing an approved action.

Permissions should reflect clinical risk. Low-risk administrative tasks may support greater automation, while consequential clinical actions may require explicit approval. Systems should also record relevant inputs, decisions, authorization events, and execution outcomes.

When uncertainty, conflicting information, or unexpected conditions arise, the system should follow defined escalation procedures rather than exceed its authority.

These controls help organizations investigate incidents, identify weaknesses, and improve deployment practices.

Call to action: AI engineers, clinical informaticians, and digital health teams, what accountability controls should every healthcare agentic AI system include? Share your practical experience.

Designing Healthcare AI Around Patient Preferences

Onyedikachi Onwurah — Thu, 15 Oct 2026 08:59:03 +0000

Healthcare AI often optimizes measurable objectives such as risk reduction, treatment response, readmission, or length of stay. These objectives are useful, but they do not capture every dimension of patient value.

Consider two patients with similar clinical profiles who have different preferences regarding treatment burden, independence, or quality of life. An algorithm that optimizes a single outcome may generate the same recommendation for both, even when their informed priorities differ.

Decision-support systems should distinguish between predicted outcomes and preference-sensitive decisions. They can present expected benefits, potential harms, uncertainty, and reasonable alternatives to support shared decision-making.

Agentic systems require additional safeguards. They should recognize actions that need patient consent, clinician authorization, or further discussion rather than proceeding solely because an action aligns with a predefined objective.

Patient preferences should not be inferred carelessly from incomplete records. Where preferences are unknown or may have changed, systems should identify the gap and facilitate appropriate human engagement.

The aim is not to encode every human value into an algorithm. It is to design AI that helps healthcare professionals make evidence-informed decisions without treating patients as interchangeable prediction targets.

Subgroup Evaluation in Healthcare AI: Looking Beyond Average Performance

Onyedikachi Onwurah — Wed, 14 Oct 2026 09:33:10 +0000

Healthcare AI models are commonly evaluated using aggregate measures such as AUROC, sensitivity, specificity and calibration. These metrics are useful, but they can conceal meaningful performance differences across patient groups.

A model may achieve strong overall discrimination while producing more false negatives in a subgroup. An AI-supported workflow may reduce average processing time while providing smaller benefits to certain populations.

These differences matter because model errors and operational outcomes can have different consequences across clinical contexts.

A robust evaluation framework should define relevant subgroups before analysis, select metrics aligned with the intended use and report uncertainty around subgroup estimates. Small sample sizes can produce unstable results, so apparent disparities should be interpreted carefully.

When gaps are identified, investigators should examine possible causes, including data completeness, measurement quality, prevalence differences, model behavior and variation in clinical workflows.

Subgroup analysis should continue after deployment because the population, data pipeline and operational environment may change.

For agentic healthcare AI, the analysis should also examine whether differences in model performance lead to differences in actions, escalation rates, access or patient outcomes.

The objective is not necessarily identical performance across every group. It is to identify and address avoidable risks while ensuring that the system remains clinically appropriate.

Aggregate performance is a starting point, not a complete account of healthcare AI quality.

Closing the Loop in Healthcare AI: From Prediction to Verified Action

Onyedikachi Onwurah — Tue, 13 Oct 2026 09:48:43 +0000

Healthcare AI evaluation often focuses on model outputs, including discrimination, calibration and predictive performance. These measures are important, but they do not fully explain whether a system improves clinical practice.

Between an AI recommendation and a patient outcome lie several distinct stages: clinical review, decision-making, intervention availability, execution and follow-up.

A recommendation may be accepted, modified, rejected or never reviewed. Each possibility has a different interpretation.

For example, a clinician may override an AI recommendation because additional evidence changes the decision. Alternatively, a useful recommendation may not be acted upon because the alert arrives too late or the required resource is unavailable.

These situations should not be grouped into a single category of recommendation failure.

A robust evaluation framework should capture recommendation status, decision rationale where appropriate, action completion, operational barriers and relevant outcomes. It should also account for confounding factors before attributing outcomes to the AI system.

Agentic systems need an additional layer of execution verification. The system should distinguish between an intended action, an attempted action and confirmed completion. Failed actions, exceptions and human interventions should be visible to the appropriate monitoring and audit processes.

Feedback should not automatically become a training signal. Clinical outcomes are influenced by many factors, and naive optimization can reinforce harmful behavior or reward the wrong objective.

The goal is a governed feedback loop that helps teams understand real-world impact while preserving clinical judgment.

A healthcare AI system should not stop at generating an output. It should help establish what happened next.

Evaluating the Causal Impact of Healthcare AI

Onyedikachi Onwurah — Mon, 12 Oct 2026 13:31:35 +0000

Healthcare AI evaluations often report predictive performance and changes in outcomes following deployment. These are useful measures, but they answer different questions.

Predictive performance describes how well a model estimates an outcome. Post-deployment outcome changes describe what happened after implementation. Neither, on its own, establishes that the AI system caused the change.

Consider a hospital that introduces AI-assisted triage and subsequently observes shorter waiting times. Staffing levels may also have increased, workflows may have changed, or patient volume may have declined.

A simple before-and-after comparison cannot reliably isolate the AI contribution.

Impact evaluation therefore requires a design suited to the intervention and clinical setting. Depending on feasibility, this may involve randomized trials, controlled implementation studies, interrupted time-series analysis or carefully designed observational comparisons.

Evaluation should also distinguish between the effect of making predictions available and the effect of acting on them. A predictive model may have little impact if clinicians cannot act on its outputs. Conversely, an agentic system may change outcomes through the actions it initiates, creating additional pathways to assess.

Researchers should consider confounding, selection effects, implementation fidelity, unintended consequences and differences across patient groups.

For agentic systems, the evaluation should examine the complete intervention pathway, from the model's output through execution and clinical response to relevant outcomes.

The core principle is simple: temporal association is not causal evidence.

Healthcare AI needs credible evidence that deployment improves care compared with an appropriate alternative, not merely evidence that favorable outcomes occurred afterward.

Closing the Loop in Healthcare AI: From Prediction to Verified Action

Onyedikachi Onwurah — Sun, 11 Oct 2026 09:27:54 +0000

Between an AI recommendation and a patient outcome lie several distinct stages: clinical review, decision-making, intervention availability, execution and follow-up.

A recommendation may be accepted, modified, rejected or never reviewed. Each possibility has a different interpretation.

These situations should not be grouped into a single category of recommendation failure.

Feedback should not automatically become a training signal. Clinical outcomes are influenced by many factors, and naive optimization can reinforce harmful behavior or reward the wrong objective.

The goal is a governed feedback loop that helps teams understand real-world impact while preserving clinical judgment.

A healthcare AI system should not stop at generating an output. It should help establish what happened next.

Designing Escalation Policies for Agentic Healthcare AI

Onyedikachi Onwurah — Sat, 10 Oct 2026 04:11:06 +0000

As healthcare AI systems become more capable of executing workflows, escalation needs to become an explicit part of system design.

A model may produce a prediction with high confidence while operating outside its validated scope. A clinical agent may encounter incomplete information, contradictory records or a decision with potentially serious consequences.

Technical confidence alone is not sufficient to determine whether autonomous action is appropriate.

A robust escalation policy should define conditions for independent action, additional evidence gathering, human approval and stopping.

These conditions can incorporate uncertainty, evidence conflicts, clinical risk, validation boundaries and the reversibility of the proposed action.

The handover should also be structured. It should communicate why escalation occurred, which evidence was considered, what remains uncertain and whether any actions have already been taken.

Escalation logic should be tested during development and monitored after deployment. Organizations should assess not only missed escalations, but also unnecessary escalations that create alert fatigue and reduce the value of automation.

For agentic systems, escalation should be enforced through the workflow architecture rather than left entirely to the model's discretion.

The design principle is straightforward: an AI system should never gain authority simply because it encounters a difficult case.

Safe autonomy depends on explicit boundaries, reliable handovers and accountable human oversight.

Source-Aware Healthcare AI: When Clinical Systems Disagree

Onyedikachi Onwurah — Fri, 09 Oct 2026 07:04:14 +0000

Healthcare AI increasingly depends on data assembled from multiple systems.

That creates an important engineering problem: source disagreement.

An EHR may contain one medication status while a pharmacy system contains another. A laboratory result may be corrected after an earlier value has already propagated to downstream systems. A clinical note may contain information that has not yet been represented in structured data.

A naive integration layer may simply select the latest value.

That can be unsafe.

Source-aware AI should reason about at least four dimensions: provenance, timestamp, reliability and clinical context.

Provenance identifies where the information originated. Timestamp helps establish temporal relevance. Reliability considers the nature of the source and how the value was generated. Clinical context helps determine whether apparently conflicting values can actually coexist or represent a meaningful change.

For agentic AI, this becomes an operational safety requirement.

Suppose an autonomous agent encounters conflicting medication information before initiating a medication-related workflow. Selecting one value without verification could transform a data-quality problem into a clinical event.

A safer architecture can include conflict detection, source prioritization rules, verification workflows and human escalation thresholds.

The important design principle is simple:

Conflicting evidence should change system behavior.

The AI should not merely produce a more confident answer from contradictory inputs.

Sometimes it should pause.

Healthcare intelligence therefore requires more than data integration. It requires reasoning about the reliability and provenance of evidence.

Safe Model Updates in Healthcare AI: From Development to Controlled Deployment

Onyedikachi Onwurah — Thu, 08 Oct 2026 10:34:44 +0000

Healthcare AI systems are not static.

New training data becomes available. Clinical guidelines change. Model architectures improve. Errors are discovered. Performance may degrade in specific populations.

Eventually, the deployed model needs to change.

The engineering challenge is making that change safely.

A new model should not automatically replace the production model simply because it performs better on a validation dataset.

A safer lifecycle includes versioned models, reproducible evaluation, subgroup analysis, shadow deployment where appropriate, staged rollout, post deployment monitoring and rollback capability.

Shadow deployment is particularly useful for high consequence systems. The new model can generate predictions without affecting clinical decisions, allowing organizations to compare its behavior against the current production model.

Model versioning is equally important. When a clinical recommendation is generated, organizations should be able to determine which model version produced it and which configuration and data pipeline supported that version.

For agentic AI, update management becomes even more important.

Changing the underlying model can change not only predictions but the actions an agent chooses to take. An update can therefore alter the behavior of an entire automated workflow.

This suggests a broader principle:

Model updates should be treated as controlled changes to a clinical system.

The objective is not to prevent continuous improvement.

It is to ensure that improvement does not become an uncontrolled experiment on patients.

Healthcare AI Needs to Account for Practice Drift

Onyedikachi Onwurah — Wed, 07 Oct 2026 08:24:29 +0000

Machine learning systems are usually evaluated against a relatively stable development environment. Healthcare rarely provides one.

Clinical practice changes continuously through guideline updates, new treatments, diagnostic technologies, workflow redesign, staffing changes, and documentation practices.

These changes can modify the data-generating process.

Consider a model trained to predict a clinical outcome using historical patient information. If treatment protocols later change, the relationship between the same patient characteristics and the outcome may change. The model may therefore experience degraded clinical validity even when conventional input distributions do not show dramatic drift.

This is practice drift.

It differs from ordinary feature drift because the underlying clinical process has changed.

A useful monitoring strategy should therefore combine model performance monitoring with clinical governance signals. Significant changes in guidelines, care pathways, diagnostic technologies, treatment patterns, or documentation should trigger review.

For some systems, the appropriate response may be recalibration. Others may require retraining or external validation. High-consequence systems may need temporary restrictions while their assumptions are reassessed.

Agentic healthcare AI makes this especially important. An agent can execute decisions consistently according to its objective, but consistency does not guarantee that its objective remains aligned with current clinical practice.

The technical lesson is simple: monitor the environment that generates the data, not only the data itself.

Healthcare AI Is a Multi-Objective Optimization Problem

Onyedikachi Onwurah — Tue, 06 Oct 2026 11:01:18 +0000

Machine learning systems are often evaluated against a clearly defined objective.

Maximize AUROC.

Minimize error.

Reduce latency.

Increase sensitivity.

In healthcare, however, optimizing one objective can affect several others.

Consider a clinical alerting system.

Increasing sensitivity may improve detection of high-risk patients, but it can also increase false positives and alert burden.

An operational AI system may reduce waiting time but create pressure on staffing.

A resource optimization system may reduce costs while affecting access or continuity.

This means healthcare AI should be treated as a multi-objective system rather than a single-metric optimization problem.

Technical evaluation should therefore consider competing objectives and constraints.

The relevant question is not simply whether the target metric improved.

It is whether the overall decision environment improved.

For agentic AI, this becomes particularly important.

An agent with authority to act can optimize its objective through real-world interventions. Without clearly defined constraints, it may achieve the local objective while creating undesirable downstream effects.

A safer architecture should therefore define not only goals, but also boundaries.

What should the system optimize?

What must it preserve?

What outcomes should it monitor?

When should it stop?

When should it escalate?

Healthcare AI should not confuse optimization with intelligence.

A system can be extremely effective at optimizing the wrong objective.

The real challenge is defining what success means before asking AI to achieve it.

Healthcare AI Needs to Understand Data Reliability

Onyedikachi Onwurah — Mon, 05 Oct 2026 13:49:29 +0000

A common assumption in machine learning is that the input data represents the underlying phenomenon we want to model.

Healthcare is rarely that simple.

Electronic health records contain measurements, observations, documentation and administrative representations of clinical reality.

These representations can be incomplete or incorrect.

A medication may remain on a list after discontinuation. A diagnosis may not be documented. A laboratory result may be affected by measurement error. A clinical note may be copied forward. A result may be technically correct but clinically outdated by the time an AI system processes it.

These are not simply model-performance problems.

They are data-reliability problems.

Healthcare AI should therefore incorporate information about provenance, freshness, measurement quality and source reliability.

For high-consequence applications, systems should be able to distinguish between trusted observations and inputs that require verification.

This is particularly important for agentic AI.

An agent may reason correctly from an unreliable input and still produce an unsafe outcome.

A useful architecture therefore needs more than a prediction layer.

It needs mechanisms for data validation, consistency checking, provenance tracking and verification before consequential actions.

The important principle is:

Correct reasoning over unreliable data can still produce an incorrect outcome.

Healthcare AI safety therefore begins before the model makes its prediction.

It begins with understanding the quality and meaning of the information entering the system.